Annual report pursuant to Section 13 and 15(d)

Statements of Stockholders??? (Deficit) Equity

v3.22.1
Statements of Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 8 $ 2,766 $ (3,658) $ (884)
Balance (in Shares) at Dec. 31, 2019   8,456,179      
Net loss (2,264) (2,264)
Issuance of common stock for cash $ 1 141 142
Issuance of common stock for cash (in Shares)   33,263      
Issuance of common stock for anti-dilution clause 104 104
Issuance of common stock for anti-dilution clause (in Shares)   24,628      
Stock-based compensation expense 231 231
Balance at Dec. 31, 2020 $ 9 3,242 (5,922) (2,671)
Balance (in Shares) at Dec. 31, 2020   8,514,070      
Net loss (10,017) (10,017)
Net proceeds from initial public offering $ 5 22,266 22,271
Net proceeds from initial public offering (in Shares)   5,000,000      
Conversion of convertible notes into common stock $ 1 3,684 3,685
Conversion of convertible notes into common stock (in Shares)   736,773      
Issuance of common stock for exercise of options 59 59
Issuance of common stock for exercise of options (in Shares)   307,317      
Issuance of common stock for anti-dilution clause 2,191 2,191
Issuance of common stock for anti-dilution clause (in Shares)   438,374      
Stock-based compensation expense 966 966
Balance at Dec. 31, 2021 $ 15 $ 32,408 $ (15,939) $ 16,484
Balance (in Shares) at Dec. 31, 2021   14,996,534